New diabetes clinical trial: A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes

Published on: March 11, 2025 at 11:00PM
Conditions: Adult Patients With Type 2 Diabetes
Interventions: Drug: HR17031 injection; Drug: insulin glargine
Sponsors: Jiangsu HengRui Medicine Co., Ltd.
Active, not recruiting
https://ift.tt/yH0onXO